Get your free ETF data sample from our comprehensive offerings. Start your free trial→

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

›ETF Issuers›Amundi›LHTC
LHTC

Amundi STOXX Europe 600 Healthcare UCITS ETF

Acc
EUR
Passive ETFEquity

The LHTC Exchange Traded Fund (ETF) is provided by Amundi. It is built to track an index: STOXX Europe 600 Health Care Index. This ETF provides synthetic exposure, by owning its shares you earn the return of the index indirectly through the use of derivatives or a swap (i.e. a contract with a financial institution which delivers the return of the index). The dividend policy is capitalization.

Advertisement

Advertisement

€145.06
-€0.82 (-0.56%) 2 days ago
6:00 AM 09/10/26 Closed
1D price range
€145.04€146.28
52W price range
€133.52€163.86
YTD Perf.
-3.85%
YTD Flows
Annualized volatility
Fund AuM
€870M
Share class AuM
€803M
TTM Yield
-
Tracking Error
Tracking Difference
Characteristics
ISIN
LU1834986900
TER
0.3%
Inception date
8/18/2006
Issuer
Amundi
Benchmark
STOXX Europe 600 Health Care Index
Replication method
Dividend policy
Capitalization
Compare similar ETFs

No content available for this fund

API
PerformanceDec 31, 2025 - Sep 10, 2026
-5%0%5%10%JANMARMAYJULSEP
Flows
Join for free to unlock
Sector exposures
Data as of 07/31/26
Healthcare
94.61%
Consumer Cyclicals
3.03%
Non-Energy Materials
1.18%
Unavailable
0.49%
Other
0.69%
Latest LHTC news
Biotech ETFs Surge as the FDA Eases Its Stance
Moving Markets · June 29, 2026
Trump’s Victory Fuels U.S. Equity ETFs Surge While Europe Faces Some Market Setbacks
Moving Markets · November 8, 2024

FAQ about LHTC

LHTC is a Passive ETF. This ETF provides exposure to European Health Care Equities.
LHTC tracks the STOXX Europe 600 Health Care Net Return Index - EUR, through a unfunded swap replication method.
LHTC carries a total expense ratio (TER) of 0.3%, indicating the annual cost for holding the fund.
LHTC was introduced to the market on August 18, 2006. It trades on Ireland, among other exchanges
Amundi STOXX Europe 600 Healthcare UCITS ETF, LHTC, is provided by Amundi. Learn more about Amundi here.
Yes, LHTC is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .
LHTC oversees €803M in assets as of September 10, 2026.
LHTC follows a capitalizing, meaning it reinvests income within the fund.
As of July 31, 2026, LHTC has significant geographic allocations in Switzerland, United Kingdom and Denmark.
As of July 31, 2026, LHTC focuses largely on Healthcare, Consumer Cyclicals and Non-Energy Materials.
As of July 31, 2026, LHTC holds 46 positions in its portfolio, with 83.99% of assets concentrated in its top 15 holdings.
As of July 31, 2026, LHTC top three holdings include Roche Holding AG, Novartis AG and AstraZeneca PLC.
The base currency of LHTC is EUR.
Top 10 holdings
Data as of 07/31/26
Roche Holding AG
15.48%
Novartis AG
15.38%
AstraZeneca PLC
13.57%
Novo Nordisk A/S
8.42%
GSK Plc
5.43%
Sanofi
4.84%
EssilorLuxottica SA
3.03%
Bayer AG
2.82%
argenx SE
2.75%
Lonza Group AG
2.55%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
ETF TOOLS
ETF ScreenerCompare ETFsCompare ETF issuersWatchlistsETF Portfolio InsightsIndustry dataETF stock exposure finder
PLATFORM
Support and feedback
ETF NEWS & RESEARCH
Latest ETF NewsETF Research ReportsGlobal ETF Survey 2025Learn ETF investing
PROFESSIONAL SOLUTIONS
Enterprise SolutionsDue Diligence ServicesETF Data Services
SOLUTIONS FOR
Institutional investorsPrivate banksFinancial advisorsFintech and mediaIndividual investors
CONTACT US
General inquiries
Press and media
Advertising opportunities
Support and feedback
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Get our newsletters
Trackinsight